drugset / Trial / NCT01336842
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if panobinostat taken with cisplatin and pemetrexed can be used safely without increasing side effects and that the combination will have a better effect than platinum-based doublet chemotherapy alone.
Timeline
- Start
- 2011-04
- Primary completion
- 2017-01
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | — | Oral |
| Background | Cisplatin | Other / unclassified | — | Intravenous |
| Background | Pemetrexed | Small molecule | — | Intravenous |